• Info
  • Insider Trading

Insider Transactions Reported by 2 Insiders of PARALLAX HEALTH SCIENCES, INC.

Location
Beverly Hills, CA

There are no Buy or Sell transactions made by insiders since 13 Mar 2025

PARALLAX HEALTH SCIENCES, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Edward W. Withrow III 10%+ Owner $9,404,881 14 Jan 2022
Calli Bucci CFO, Secretary, Treasurer, Director $257,500 31 Dec 2021

Recent Insider Transactions by Companies or Individuals for PARALLAX HEALTH SCIENCES, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Edward W. Withrow III COMMON STOCK Other 28.4% 20,541,826 92,972,618 14 Jan 2022 By Huntington Chase LLC
Edward W. Withrow III PREFERRED STOCK (SERIES A) Other 99.2% 396,339 796,071 06 Nov 2021 By Huntington Chase Financial Group
Edward W. Withrow III COMMON STOCK Other 28.2% 15,921,420 72,430,792 06 Nov 2021 By Huntington Chase LLC
Edward W. Withrow III PREFERRED STOCK (SERIES A) Other -100% -796,071 0 06 Nov 2021 By Huntington Chase Financial Group
Calli Bucci WARRANTS Disposed to Issuer -1.44% -15,000 1,030,000 30 Sep 2021 Direct
Edward W. Withrow III STOCK OPTION Disposed to Issuer -75% -3,000,000 1,000,000 31 Mar 2021 By Huntington Chase LLC
Edward W. Withrow III COMMON STOCK Other 7,631,245 7,631,245 06 Dec 2012 Direct
Edward W. Withrow III COMMON STOCK Other 65.5% 5,000,000 12,631,245 06 Dec 2012 By Spouse
Edward W. Withrow III COMMON STOCK Other 45.3% 5,721,900 18,353,145 06 Dec 2012 By Withrow Sinclair & Co.
Edward W. Withrow III COMMON STOCK Other 207.9% 38,156,227 56,509,372 06 Dec 2012 By Montecito BioSciences Ltd.
Edward W. Withrow III PREFERRED STOCK (SERIES A) Other 10% 36,339 399,732 30 Sep 2011 By Huntington Chase Financial Group
* An asterisk sign (*) next to the price indicates that the price is likely invalid.